Evidence map›Paper›PMID 39111992›Full record

GuidelineJACC. Cardiovascular imaging2024

Pericardial Diseases: International Position Statement on New Concepts and Advances in Multimodality Cardiac Imaging.

Allan L Klein, Tom Kai Ming Wang, Paul C Cremer, Antonio Abbate, Yehuda Adler, Craig Asher, Antonio Brucato, Michael Chetrit, Brian Hoit, Christine L Jellis and 12 more

Abstract readReviewPractice Guideline
In one paragraph

Guideline in JACC. Cardiovascular imaging, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 85 papers.

0numbers the graph read from it
0cells of the map it votes in
85citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

85 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Review

25 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Allan L KleinCenter for the Diagnosis and Treatment of Pericardial Diseases, Section of Cardiovascular Imaging, Robert and Suzanne Tomsich Department of Cardiovascular Medicine, Sydell and Arnold Miller Family Heart, Vascular, and Thoracic Institute, Cleveland Clinic, Cleveland, Ohio, USA. Electronic address: kleina@ccf.org.
Tom Kai Ming WangCenter for the Diagnosis and Treatment of Pericardial Diseases, Section of Cardiovascular Imaging, Robert and Suzanne Tomsich Department of Cardiovascular Medicine, Sydell and Arnold Miller Family Heart, Vascular, and Thoracic Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Paul C CremerDepartments of Medicine, Division of Cardiology, Bluhm Cardiovascular Institute, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Antonio AbbateBerne Cardiovascular Research Center, Division of Cardiovascular Medicine, Department of Medicine, University of Virginia, Charlottesville, Virginia, USA.
Yehuda AdlerSackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Craig AsherRobert and Suzanne Tomsich Department of Cardiovascular Medicine, Cleveland Clinic Weston Hospital, Weston, Florida, USA.
Antonio BrucatoUniversity of Milano, Department of Biomedical and Clinical Science, Ospedale Fatebenefratelli, Milano, Italy.
Michael ChetritDepartment of Cardiovascular Medicine, McGill University Health Centre, Montreal, Quebec, Canada.
Brian HoitHarrington Heart and Vascular Institute, University Hospitals Cleveland Medical Center, Case Western Reserve University, Cleveland, Ohio, USA.
Christine L JellisCenter for the Diagnosis and Treatment of Pericardial Diseases, Section of Cardiovascular Imaging, Robert and Suzanne Tomsich Department of Cardiovascular Medicine, Sydell and Arnold Miller Family Heart, Vascular, and Thoracic Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Deborah H KwonCenter for the Diagnosis and Treatment of Pericardial Diseases, Section of Cardiovascular Imaging, Robert and Suzanne Tomsich Department of Cardiovascular Medicine, Sydell and Arnold Miller Family Heart, Vascular, and Thoracic Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Martin LeWinterLarner College of Medicine, University of Vermont Medical Center, Vermont, USA.
David LinAbbott Northwestern's Heart Hospital, Allina Health Minneapolis Heart Institute, Minneapolis, Minnesota, USA.
Sushil Allen LuisDivision of Structural Heart Disease, Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Vartan MardigyanDepartment of Medicine, Jewish General Hospital, Montreal, Quebec, Canada.
Jae K OhDivision of Structural Heart Disease, Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Karen G OrdovasDepartment of Radiology, University of Washington, Seattle, Washington, USA.
E Rene RodriugezDepartment of Pathology, Cleveland Clinic, Cleveland, Ohio, USA.
Aldo L SchenoneCardiology Department, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York, USA.
Carmela D TanDepartment of Pathology, Cleveland Clinic, Cleveland, Ohio, USA.
Brittany WeberHeart and Vascular Center, Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston Massachusetts, USA.
Massimo ImazioDepartment of Medicine, University of Udine, Udine, Italy; Cardiothoracic Department, University Hospital Santa Maria della Misericordia, Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy.

Funding

Improving Phenotypic Classification and Prediction of Treatment Outcomes in Patients with Non-ischemic Cardiomyopathy and Functional Mitral RegurgitationR01HL170090 · NHLBI · CLEVELAND CLINIC LERNER COM-CWRU · PI DEBORAH KWON · 2023 to 2026
$3.1M
Advanced CV imaging and immunophenotyping to study coronary vascular health in psoriasisK23HL159276 · NHLBI · UT SOUTHWESTERN MEDICAL CENTER · PI WEBER, BRITTANY NICOLE · 2021 to 2025
$962k
NHLBI NIH HHS K23 HL159276NHLBI NIH HHS R01 HL170090
6 · The paper itself

Abstract

Pericardial diseases have gained renewed clinical interest, leading to a renaissance in the field. There have been many recent advances in pericardial diseases in both multimodality cardiac imaging of diagnoses, such as recurrent, transient constrictive and effusive-constrictive pericarditis, and targeted therapeutics, especially anti-interleukin (IL)-1 agents that affect the inflammasome as part of autoinflammatory pathophysiology. There remains a large educational gap for clinicians, leading to variability in evaluation and management of these patients. The latest pericardial imaging (American Society of Echocardiography, European Association of Cardiovascular Imaging) and clinical guidelines (European Society of Cardiology) are >8-10 years of age and may not reflect current practice. Recent clinical trials involving anti-IL-1 agents in recurrent pericarditis, including anakinra (AIRTRIP), rilonacept (RHAPSODY), and goflikicept have demonstrated their efficacy. The present document represents an international position statement from world leaders in the pericardial field, focusing on novel concepts and emphasizing the role of multimodality cardiac imaging as well as new therapeutics in pericardial diseases.

Indexed as

ConsensusMultimodal ImagingPericardiumPredictive Value of TestsCardiac Imaging TechniquesDiffusion of InnovationHumansPericarditisPericarditis, ConstrictivePrognosiscardiac magnetic resonanceconstrictive pericarditisechocardiographypericardial effusionpericarditispericardium

Identifiers

PMID39111992
PMCPMC12156183

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.